Alvin (Al) Powers
-
November 29, 2018
Beta cell biomarker findings may speed diabetes research
Researchers at Vanderbilt University Medical Center have identified a biomarker for insulin-producing beta cells. Their finding, reported this month in the journal Cell Metabolism, could lead to improved ways to study and treat diabetes. -
March 6, 2018
Discovery by Vanderbilt-led group could lead to improved diabetes treatment
Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D). -
November 9, 2017
New phenotyping program to bolster global diabetes research efforts
The use of human pancreatic islets to conduct diabetes-related research has greatly expanded in recent years, and a Human Islet Phenotyping Program (HIPP) at Vanderbilt University Medical Center has been established to provide important islet data to investigators worldwide. -
June 15, 2017
VUMC team’s discovery could lead to new diabetes treatment
-
June 8, 2017
NIDDK renews Vanderbilt’s diabetes research grant
The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). -
May 4, 2017
Three faculty members elected to Association of American Physicians
The Association of American Physicians (AAP) is an honorary medical society founded in 1885 by Sir William Osler and six other physicians for “the advancement of scientific and practical medicine.” This year, 60 additional physician scientists were elected to the association, including three Vanderbilt faculty members. -
December 8, 2016
Making human beta cells reproduce
A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells.